Fisher Asset Management LLC Has $13.31 Million Holdings in Core Laboratories Inc. (NYSE:CLB)

Fisher Asset Management LLC grew its holdings in Core Laboratories Inc. (NYSE:CLBFree Report) by 21.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 753,555 shares of the oil and gas company’s stock after purchasing an additional 133,375 shares during the quarter. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $13,308,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Russell Investments Group Ltd. grew its holdings in Core Laboratories by 48.3% during the 4th quarter. Russell Investments Group Ltd. now owns 112,290 shares of the oil and gas company’s stock worth $1,983,000 after acquiring an additional 36,560 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Core Laboratories by 33.4% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 138,951 shares of the oil and gas company’s stock valued at $2,454,000 after purchasing an additional 34,765 shares during the last quarter. GAMMA Investing LLC acquired a new position in Core Laboratories in the fourth quarter valued at about $48,000. Illinois Municipal Retirement Fund lifted its stake in Core Laboratories by 10.4% in the fourth quarter. Illinois Municipal Retirement Fund now owns 27,921 shares of the oil and gas company’s stock valued at $493,000 after buying an additional 2,641 shares during the period. Finally, Louisiana State Employees Retirement System bought a new position in Core Laboratories during the fourth quarter worth about $413,000. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Stock Up 1.4 %

Shares of CLB stock opened at $15.92 on Monday. The company has a market capitalization of $746.65 million, a price-to-earnings ratio of 18.09, a P/E/G ratio of 0.90 and a beta of 2.40. Core Laboratories Inc. has a 12-month low of $13.82 and a 12-month high of $27.94. The firm has a fifty day moving average of $16.50 and a 200-day moving average of $17.30. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68.

Core Laboratories (NYSE:CLBGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.02. The company had revenue of $129.64 million for the quarter, compared to analyst estimates of $124.47 million. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. As a group, equities research analysts predict that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Monday, May 6th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.25%. The ex-dividend date of this dividend is Friday, May 3rd. Core Laboratories’s payout ratio is 4.55%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Stifel Nicolaus lifted their price objective on shares of Core Laboratories from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. Bank of America decreased their price target on shares of Core Laboratories from $17.00 to $16.00 and set an “underperform” rating for the company in a report on Monday, April 15th. Finally, StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, January 20th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to MarketBeat, Core Laboratories has an average rating of “Hold” and a consensus price target of $18.75.

View Our Latest Analysis on CLB

Core Laboratories Company Profile

(Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Featured Stories

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLBFree Report).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.